MedTrace Logo

Cognitive-behavioral (CBT) in ESRD Patients With Depression

NCT02011139 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2015-11-20

No results posted yet for this study

Summary

Depression is common in end-stage renal disease (ESRD) patients and has a negative effect on the quality of life, functional ability, and mortality, with a prevalence rate as high as 20-25%. However, it is hard to use anti-depressant due to the safety issue, and there has been little data so far particularly in terms of randomized clinical trials. Here, we investigate the effect of cognitive-behavioral group therapy for enhancing mental health and quality of life in patients with ESRD.

Conditions

  • Kidney Failure, Chronic
  • Depression
  • Quality of Life

Interventions

BEHAVIORAL

Cognitive-behavioral group therapy

Sponsors & Collaborators

  • Seoul National University Boramae Hospital

    lead OTHER

Principal Investigators

  • Chun Soo Lim, M.D. PhD · Seoul National University Boramae Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2014-09-30
Completion
2014-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02011139 on ClinicalTrials.gov